氨苄西林磁性明胶药物微球的制备及控制释放

将药物封装入一个输送系统,以便在适当时间内持续控制药物释放.为此,利用明胶的生物相容性,选用难溶性氨苄西林(AMP)为药物模型,Fe3O4作为磁性内核,戊二醛作交联固化剂,液体石蜡为有机分散介质,采用反相悬液冷冻凝聚法(RPSCC)制备出了磁性AMP明胶核壳微球.用SEM、FT-IR和UV/Vis光谱等考察了药物微球的结构和外观形貌,以及药物在包封后的性质.结果表明磁性明胶药物微球的粒径小于20 μm.氨苄西林微球载药率(w/w)为7.1%,Fe3O4的含量为22.1%,微球包裹率为65.13%.7h内释放的药物占总含药量的72.3%.微球的缓释性能良好.     

Pickering乳液聚合制备共价键连接的磁性复合微球

以先后用TEOS和KH570改性的表面含双键的Fe3O4纳米粒子为唯一乳化剂,以甲基丙烯酸甲酯(MMA)为单体,制备了稳定的Pickering乳液,并通过Pickering乳液聚合制备了以PMMA为核、Fe3O4为壳的Fe3O4/PMMA磁性复合微球。用粒度分析仪、光学显微镜、扫描电镜、傅立叶红外光谱仪、热失重分析仪、振动样品磁强计对所制备的改性Fe3O4纳米粒子和磁性复合微球的结构、形态和性能进行了表征。结果表明:通过Fe3O4表面双键与单体的共聚,使微球表面的Fe3O4通过化学键与PMMA连接,所制备磁性复合微球粒径为15～20μm、磁含量为4.9%、比饱和磁化强度为2.38emu.g-1,可在外磁场下方便地分离。     

Fe_3O_4/P(AA-MMA-GMA)磁性复合微球的制备及其偶联抗体的性能

采用新型的无皂乳液聚合法制备磁性复合微球,即以丙烯酸(AA)、甲基丙烯酸甲酯(MMA)和甲基丙烯酸缩水甘油酯(GMA)为单体,1,1-二苯基乙烯为自由基控制剂,无皂乳液聚合制备了一种磁性复合微球Fe3O4/P(AA-MMA-GMA)。以所制备的Fe3O4/P(AA-MMA-GMA)微球为载体,通过共价偶联山羊抗兔IgG抗体,得到了一种免疫磁性复合微球。研究表明,Fe3O4/P(AA-MMA-GMA)微球表面带有环氧基,粒径为626nm,具有超顺磁性。0.5mgFe3O4/P(AA-MMA-GMA)微球与200μg山羊抗兔IgG抗体在pH=7.4的磷酸盐缓冲液中于25℃反应16h,可得到一种免疫磁性复合微球,其山羊抗兔IgG的偶联量为124μg,且该免疫磁性复合微球可特异性结合兔抗肌动蛋白α。     

沉积法制备Fe_3O_4/P(AA-DVB)磁性复合微球

通过静电吸附与机械力共同作用的沉积法制备得到了Fe3O4/P(AA-DVB)磁性复合微球。分别采用无皂乳液聚合和共沉淀法制备得到单分散的P(AA-DVB)胶体粒子及Fe3O4纳米粒子,在静电吸附和机械力作用下,将Fe3O4纳米粒子附着并嵌入P(AA-DVB)胶体粒子表面及内部,制备得到Fe3O4/P(AA-DVB)磁性复合微球。该方法的优势在于最终磁性复合微球的粒径及粒径分布可以由前驱体P(AA-DVB)胶体粒子调控。磁性复合微球表面和内部Fe3O4纳米粒子的分布及磁含量可以由机械力作用时间进行调节。所制备的Fe3O4/P(AA-DVB)磁性复合微球平均粒径为542 nm,磁含量范围在11%~33%内可调。     

环氧基多孔磁性复合微球的制备及性质

以聚醚为致孔剂,通过悬浮聚合法制备了表面带有环氧基的多孔磁性复合微球。用红外光谱(FTIR)、扫描电子显微镜(SEM)、磁强计(VSM)、压汞法等对其进行了表征,考察了分散剂质量分数对多孔磁性微球性能的影响。结果表明,该微球粒径为35～50μm,表面有不规则孔道,w(Fe3O4)≈15.8%,饱和磁化强度8.98 emu/g。水相中w(PVA)由1.5%升至3%时,微球平均粒径由130μm变为40μm,而平均孔径亦由144 nm降为39 nm。     

多孔Fe_3O_4/C磁性复合微球的制备及其对RhB的吸附性能

以油酸同步修饰共沉淀法制备的Fe3O4为铁磁性原料,通过悬浮聚合的方法制备Fe3O4/PDVB磁性复合微球,氮气氛围下烧结最终得到了具有多孔结构的Fe3O4/C磁性复合微球。采用SEM、TGA、VSM及压汞仪等手段对复合微球的形貌、磁性能和孔性能等进行了表征。结果表明,微球平均粒径约为120μm,磁含量和最大比饱和磁化强度分别为49.29%和39.31 emu/g,平均孔径和累积比表面积分别为382.5 nm和21.41 m2/g。将制得的多孔Fe3O4/C磁性复合微球用于罗丹明B(RhB)的吸附研究,微球表现出了良好的吸附效果和重复使用性。     

Fe_3O_4/SiO_2核壳复合磁性微球的制备和表征

以溶剂热法制备的高磁饱和强度Fe3O4纳米颗粒为核,正硅酸乙酯(TEOS)为前驱体,采用Stber方法,在乙醇/水溶液中,通过氨水催化水解硅醇盐,制得核壳结构的Fe3O4/SiO2复合磁性微球。对制备的样品的物相结构、形貌和磁性能进行了测试表征。结果表明:制备的Fe3O4/SiO2磁性微球呈球形,粒径分布均一,SiO2壳层圆整光滑,厚度为40~70nm。X射线衍射分析显示,Fe3O4/SiO2磁性微球具有尖锐的Fe3O4特征衍射峰,表明包覆过程没有破坏Fe3O4的晶体结构,其室温下的磁滞回线呈顺磁性,且比饱和磁化强度为30A·m2/kg。此外,对SiO2壳层的包覆机理进行了探究。     

中国化学化工文摘聚合物乳液题录

O632 .52　聚丙烯酸甲酯 -二乙烯苯微球的制备 /严希康 ,张荣升 ,杨亚琴 ,王宏 (华东理工大学生物反应器工程国家重点实验室 ) //华东理工大学学报 .— 1 999,2 5( 1 ) .— 39- 4 2　通过无皂乳液聚合方制备了单分散性好的丙烯酸甲酯 ( MA) -二乙烯苯 ( DVB)交联微球。研究了引发剂、单体、交联剂的用量、温度、搅拌速率、离子强度对聚合反应速率和微球粒径的影响。得到了外形较规则、粒径为 730 nm左右、分布均匀的交联丙烯酸甲酯 -二乙烯苯微球 ,其制备条件是 :以双蒸馏水为反应体系 ,C(MA) 0 =0 .78lmol/L,CDVB=0 .0 67mol/L,T=70…     

Fe_3O_4/羧甲基壳聚糖磁性载药微球的制备及释药性能

通过乳化交联法制备了负载有抗癌药物5-氟尿嘧啶的Fe3O4/羧甲基壳聚糖磁性载药微球。利用红外光谱(IR)和扫描电镜(SEM)对载药微球的结构与形貌进行了表征,研究了影响载药微球载药和释药性能的因素。IR测试显示载药微球中含有磁性Fe3O4;SEM照片显示载药微球尺寸均一,表面光滑。确定制备磁性载药微球的最佳条件为:5-氟尿嘧啶0.5g、磁性Fe3O40.2g、戊二醛8mL;磁性载药微球在温度为35~40℃、pH值为5.2的缓冲溶液中释药量达到峰值,适用于人体十二指肠肿瘤的治疗。     

稳定剂NH_4H_2PO_4用于胶体Sb_2O_5阻燃剂的制备及稳定作用研究

采用NH4 H2 PO4 为稳定剂 ,以H2 O2 为氧化剂 ,将Sb2 O3 氧化 ,制得胶体Sb2 O5。通过正交实验法优选出最佳制备工艺条件为 :n(H2 O2 ) /n(Sb2 O3 ) =3,m (H2 O) /m(Sb2 O3 ) =3～ 4,m(NH4 H2 PO4 ) /m(Sb2 O3 ) =0 0 5 ,温度 90℃ ,反应 1 5h。该条件下 ,Sb2 O3 转化率达到 98%,制得胶体中w(Sb2 O5) =2 1%,透光率 90 %,胶粒平均粒径为 84nm左右。实验结果表明 :采用NH4 H2 PO4 作为稳定剂 ,可使Sb2 O5粒子稳定存在 1a以上而不发生聚沉。     

α‐Amylase immobilized by Fe3O4/poly(styrene‐co‐maleic anhydride) magnetic composite microspheres: Preparation and characterization

Fe₃O₄/poly(styrene‐co‐maleic anhydride) core–shell composite microspheres, suitable for binding enzymes, were prepared using magnetite particles as seeds by copolymerization of styrene and maleic anhydride. The magnetite particles were encapsulated by polyethylene glycol, which improved the affinity between the magnetite particles and the monomers, thus showing that the size of the microspheres, the amount of the surface anhydrides, and the magnetite content in the composite are highly dependent on magnetite particles, comonomer ratio, and dispersion medium used in the polymerization. The composite microspheres, having 0.08–0.8 μm diameter and containing 100–800 μg magnetite/g microspheres and 0–18 mmol surface‐anhydride groups/g microsphere, were obtained. Free α‐amylase was immobilized on the microspheres containing reactive surface‐anhydride groups by covalent binding. The effects of immobilization on the properties of the immobilized α‐amylase [magnetic immobilized enzyme (MIE)] were studied. The activity of MIE and protein binding capacity reached 113,800 U and 544.3 mg/g dry microspheres, respectively. The activity recovery was 47.2%. The MIE had higher optimum temperature and pH compared with those of free α‐amylase and showed excellent thermal, storage, pH, and operational stability. Furthermore, it can be easily separated in a magnetic field and reused repeatedly. © 2004 Wiley Periodicals, Inc. J Appl Polym Sci 95: 328–335, 2005     

Fe_3O_4/P(ST-AA)核—壳复合微球的制备和表征

本文以磁性氧化铁胶体粒子为种子,运用分散聚合法,制备出具有磁响应性Fe_3O_4/P(SI-AA)核—壳复合微球。考察了复合微球的形态及结构,测定了复合徽球的粒径和磁响应性,研究了分散介质,引发剂,聚合单体和种子粒子等因素对复合徽球形成的影响。适当调整有关反应条件,采用分散聚合法,可以使复合微球粒径达到23.0μm,磁性氧化铁含量达到9.0mg/s。     

磁性聚苯乙烯微球研究:丙烯醛和苯乙烯的共聚与表征

用聚乙二醇修饰磁性氧化铁粒子 ,作为聚合种子投入乙醇 /水分散介质中 ,进行丙烯醛和苯乙烯的共聚 ,得到了微米级的磁性复合微球。考察了磁性种子 ( Fe3 O4-PEG)、丙烯醛、苯乙烯、引发剂和分散介质对共聚体系和复合微球形成的影响。微球以 Fe3 O4晶粒为内核 ,苯乙烯与丙烯醛的共聚物为外壳 ,且表面分布一定数量的醛基。随共聚条件改变 ,微球粒径、表面醛基和磁响应性亦发生变化     

磁性琼脂糖复合微球的制备和性质

采用乳化复合技术制备出粒径为２０～３００ｎｍ、分散系数为０．０９０～０．６０１、Ｆｅ３Ｏ４含量（ｗ）为７．５％～６１．３％的具有磁核的琼脂糖复合微球。该微球呈珠形,在４～９０℃的水介质中形成均匀稳定的分散液,在０．０５Ｗｂ／ｍ２的弱磁场中具强磁响应性。制备微球的最佳条件是：琼脂糖用量１２．５～８７．５ｍｇ／ｍｌ,氯化亚铁用量１５～１２０ｍｇ／ｍｌ,ｐＨ＞１０。     

磁性聚醋酸乙烯酯微球的制备及表面功能化修饰

在油酸包覆的Fe3O4磁流体存在条件下,以醋酸乙烯酯为聚合单体,二乙烯苯为交联剂,过氧化苯甲酰为引发剂,聚乙烯醇为稳定剂,采用改良悬浮聚合法制备了粒径在数微米之间的磁性聚醋酸乙烯酯微球,对制备的磁性微球进行了表面功能化修饰。利用扫描电镜、振动样品磁强计和Fourier变换红外光谱分别检测了磁性微球的形貌、磁性能以及微球表面修饰的活性功能基团。结果表明:微球大小在1～7μm,平均粒径为3.8μm,粒径分布相对较窄;比饱和磁化强度为15.0emu/g,具有超顺磁性。     

Synthesis and characterization of composite magnetic microspheres of artemisia seed gum and chitosan

In this study, composite magnetic microspheres of artemisia seed gum and chitosan were prepared in a well‐shaped spherical form with a size range of 230–460 μm by the suspension crosslinking technique for use in the application of magnetic carrier technology. The magnetic material used in the preparation of the composite microspheres was prepared by precipitation from FeCl₃ and FeSO₄ solution in basic medium. The morphological, magnetic properties, and the functional groups of the microspheres were characterized by different techniques (i.e., SEM, magnetometry, and FTIR). The results demonstrated that the stirring rate of the suspension and the Fe₃O₄/chitosan ratio are the most effective parameters for the average of the size distributions and the magnetic quality of the microspheres, while the amount of artemisia seed gum and Tween‐80 have no significant effect on these properties. The best magnetic quality of the composite magnetic microspheres is around 4.08 emu/g microspheres at 10 KG magnetic field intensity. The thermal stability of the composite magnetic microspheres was measured by using DSC methods. © 2006 Wiley Periodicals, Inc. J Appl Polym Sci 103: 3045–3049, 2007     

Mono-Sized Anion-Exchange Magnetic Microspheres for Protein Adsorption

In this study, mono-sized anion-exchange microspheres with polyglycidylmethacrylate were engineered and processed to introduce magnetic granules by penetration–deposition approaches. The obtained magnetic microspheres showed a uniform particle diameter of 1.235 μm in average and a good spherical shape with a saturation magnetic intensity of 12.48 emu/g by VSM and 12% magnetite content by TGA. The magnetic microspheres showed no cytotoxicity when the concentration was below 10 μg/mg. The magnetic microspheres possess respective adsorption capacity for three proteins including Bovine albumin, Hemoglobin from bovine blood, and Cytochrome C. These magnetic microspheres are also potential biomaterials as targeting medicine carriers or protein separation carriers at low concentration.     

羧基化磁性微球固定化谷氨酸脱羧酶

通过化学共沉淀法结合高锰酸钾氧化制备羧基化Fe₃O₄磁性微球，以该磁性微球作为载体，固定化谷氨酸脱羧酶。利用热重分析（TGA（、透射电镜（TEM（及振动样品磁强计（VSM（对羧基化磁性微球进行表征，结果表明该磁性微球磁含量约为95.1%，粒径均一，呈近似球形且具有超顺磁性。通过对固定化酶进行傅里叶红外光谱（FT-IR（、VSM和X射线衍射（XRD（分析，确定磁性微球载体与谷氨酸脱羧酶分子间形成酰胺键，实现共价结合且固定化酶前后粒子晶形完整，均具有良好的磁响应能力和超顺磁性。与游离谷氨酸脱羧酶相比，固定化酶的热稳定性和酸碱耐受性均有不同程度的提高，且制备的固定化酶重复使用10批后相对酶活力仍大于90%。     

大粒径磁性高分子微球的合成

本文研究了苯乙烯、丙烯酸等单体在磁性氧化铁(E_((?)3)O_4)的醇/水分散体系中的聚合行为。为了改善磁性氧化铁粒子与苯乙烯单体间的亲合性,加入聚乙二醇作为分散剂和稳定剂,制备出粒径为30～1000μm的具有磁响应性的聚苯乙烯微球。研究了控制聚合区域的方法,考察了分散稳定剂、分散介质、引发剂种类和用量、反应时间等因素对聚合行为及微球形成的影响。     

Preparation of magnetic poly(lactic‐co‐glycolic acid) microspheres with a controllable particle size based on a composite emulsion and their release properties for curcumin loading

Because of their unique magnetic features and good biocompatibility, magnetic poly(lactic‐co‐glycolic) acid (PLGA) microspheres have great application potential in magnetic targeted drug‐delivery systems. In this research, magnetic PLGA microspheres with controllable particle sizes were successfully prepared from a composite emulsion with a T‐shaped microchannel reactor. A water‐in‐oil‐in‐water composite emulsion was generated by the injection of a dichloromethane/gelatin water‐in‐oil initial emulsion into the microchannel together with a coating aqueous phase, that is, the aqueous solution of glucose and poly(vinyl alcohol). The mean particle size of the microspheres could be controlled by the manipulation of the osmotic pressure difference between the internal and external aqueous phases via changes in the glucose concentration. Curcumin, a drug with an inhibitory effect on tumor cells, was used to exemplify the release properties of the magnetic PLGA microspheres. We found that the mean particle size of the microspheres ranged from 16 to 207 μm with glucose concentrations from 0 to 20 wt %. The resulting microspheres showed a rapid magnetic response, good superparamagnetism, and a considerable magnetocaloric effect, with a maximum magnetic entropy of 0.061 J·kg^?1·K^?1 at 325 K. An encapsulation efficiency of up to 77.9% was achieved at a loading ratio of 3.2% curcumin. A release ratio of 72.4% curcumin from the magnetic PLGA microspheres was achieved within 120 h in a phosphate‐buffered solution. The magnetic PLGA microspheres showed potential to be used as drug carriers for magnetic targeted tumor therapy. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2016 , 133, 43317.